{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:12:33Z","timestamp":1790349153772,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22388101"],"award-info":[{"award-number":["22388101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["2025YFC3507904"],"award-info":[{"award-number":["2025YFC3507904"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.apsb.2026.05.027","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:06:06Z","timestamp":1780038366000},"page":"4314-4349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual-driven by regulatory science and policy reconstruction: Traditional Chinese medicine (TCM) new drugs accelerate development\u2014A critical review of highlights in registration and regulation of TCM and natural medicine new drugs in China (2021\u20132025)"],"prefix":"10.1016","volume":"16","author":[{"given":"Junning","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-6360","authenticated-orcid":false,"given":"Haibo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangfei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanmei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.05.027_bib1","first-page":"3489","article-title":"Forty years of building and innovating China's scientific regulatory system for traditional Chinese medicine","volume":"50","author":"Zhao","year":"2025","journal-title":"J Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib2","series-title":"report2024 annual drug evaluation report","year":"2025"},{"key":"10.1016\/j.apsb.2026.05.027_bib3","series-title":"76 innovative drugs approved for market release in China in 2025","year":"2026"},{"key":"10.1016\/j.apsb.2026.05.027_bib4","series-title":"Regulatory science of traditional Chinese medicine","author":"Zhao","year":"2024"},{"key":"10.1016\/j.apsb.2026.05.027_bib5","first-page":"507","article-title":"The scientific advancement of China's drug regulation and the development of regulatory science","volume":"54","author":"Zhao","year":"2024","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.apsb.2026.05.027_bib6","first-page":"3","article-title":"Construction and development prospects of China's pharmaceutical regulatory science system","volume":"40","author":"Zhao","year":"2024","journal-title":"Pharmacol Clin Appl Tradit Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib7","series-title":"Regulatory policies, laws, and technical guidelines for traditional Chinese medicine in China","author":"Zhao","year":"2023"},{"key":"10.1016\/j.apsb.2026.05.027_bib8","first-page":"4","article-title":"Strategies and prospects for building an excellent regulatory system for traditional Chinese medicine","author":"Zhao","year":"2024","journal-title":"China Food Drug Regulation"},{"key":"10.1016\/j.apsb.2026.05.027_bib9","series-title":"2025 annual review of China CDE drug applications","year":"2026"},{"key":"10.1016\/j.apsb.2026.05.027_bib10","series-title":"2025 drug review Wrap-Up: which trends will define the future? Data source: Pharmadeep\u2014Drug registration and acceptance database","year":"2026"},{"key":"10.1016\/j.apsb.2026.05.027_bib11","series-title":"Monthly Report and Annual Summary of traditional Chinese medicine new drug acceptance and approval for December 2025","year":"2026"},{"key":"10.1016\/j.apsb.2026.05.027_bib12","series-title":"Monthly Report and Annual Summary on the acceptance and review of classic prescriptions and identical formulas for December 2025","year":"2026"},{"key":"10.1016\/j.apsb.2026.05.027_bib13","series-title":"2023 annual drug evaluation report","year":"2024"},{"key":"10.1016\/j.apsb.2026.05.027_bib14","series-title":"2022 annual drug review report","year":"2023"},{"key":"10.1016\/j.apsb.2026.05.027_bib15","series-title":"2021 annual drug review report","year":"2022"},{"key":"10.1016\/j.apsb.2026.05.027_bib16","series-title":"2020 annual drug review report","year":"2021"},{"key":"10.1016\/j.apsb.2026.05.027_bib17","series-title":"2025 traditional Chinese medicine new drug approval report card: classic formulas lead innovation! China pharmaceutical yearbook","year":"2026"},{"key":"10.1016\/j.apsb.2026.05.027_bib18","unstructured":"Approval status of innovative traditional Chinese medicine drugs in China in 2025, China pharmaceutical industry information Center pharma ONE drug R&D big data platform. Available from: https:\/\/www.cphiic.com\/pageIndex?id=688&type=1."},{"key":"10.1016\/j.apsb.2026.05.027_bib19","series-title":"Accepted drug varieties information","year":"2025"},{"key":"10.1016\/j.apsb.2026.05.027_bib20","series-title":"Annual report on progress of clinical trials for new drug registration in China (2024)","year":"2025"},{"key":"10.1016\/j.apsb.2026.05.027_bib21","series-title":"Annual report on progress of clinical trials for new drug registration in China (2023)","year":"2024"},{"key":"10.1016\/j.apsb.2026.05.027_bib22","series-title":"Annual report on progress of clinical trials for new drug registration in China (2022)","year":"2023"},{"key":"10.1016\/j.apsb.2026.05.027_bib23","series-title":"Annual report on progress of clinical trials for new drug registration in China (2021)","year":"2022"},{"key":"10.1016\/j.apsb.2026.05.027_bib24","series-title":"Annual report on the status of clinical trials for new drug registration in China (2020)","year":"2021"},{"key":"10.1016\/j.apsb.2026.05.027_bib25","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/cac2.12528","article-title":"Unveiling quality of clinical trials in China: from concern to confirmation","volume":"44","author":"Huang","year":"2024","journal-title":"Cancer Commun"},{"key":"10.1016\/j.apsb.2026.05.027_bib26","first-page":"2465","article-title":"Analysis of characteristics of phase II clinical trials for new traditional Chinese medicine drugs registered from 2015 to 2024","volume":"34","author":"Lei","year":"2025","journal-title":"Chin J New Drugs"},{"key":"10.1016\/j.apsb.2026.05.027_bib27","doi-asserted-by":"crossref","DOI":"10.59717\/j.xinn-med.2025.100117","article-title":"Rigorous clinical trials for traditional Chinese herbal medicine: challenge and opportunity","volume":"3","author":"Wang","year":"2025","journal-title":"Innov Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib28","first-page":"4233","article-title":"Retrospective analysis of unapproved clinical trial applications for new Chinese herbal compound drugs from 2005 to 2020","volume":"53","author":"Zhou","year":"2022","journal-title":"Chin Herb Drugs"},{"key":"10.1016\/j.apsb.2026.05.027_bib29","first-page":"805","article-title":"Discussion on issues and solutions in clinical trial design for new traditional Chinese medicines from a quality control perspective","volume":"33","author":"Tan","year":"2024","journal-title":"Chin J New Drugs"},{"key":"10.1016\/j.apsb.2026.05.027_bib30","first-page":"2358","article-title":"Analysis and reflections on the approval and market launch of innovative traditional Chinese medicines since 2020","volume":"34","author":"Wu","year":"2025","journal-title":"Chin J New Drugs"},{"key":"10.1016\/j.apsb.2026.05.027_bib31","first-page":"12","article-title":"Comprehensive analysis of traditional Chinese medicine new drug registration review from 2021 to 2024: data insights and trend outlook","volume":"37","author":"Zhang","year":"2025","journal-title":"Strait Pharmacy"},{"key":"10.1016\/j.apsb.2026.05.027_bib32","first-page":"1197","article-title":"A decade of development in pharmaceutical regulatory science (2010\u20132020): a retrospective","volume":"43","author":"Liu","year":"2020","journal-title":"Drug Evaluation Research"},{"key":"10.1016\/j.apsb.2026.05.027_bib33","first-page":"5132","article-title":"Regulatory science research on new traditional Chinese medicines based on the whole life cycle concept","volume":"52","author":"Huang","year":"2021","journal-title":"Chin Herb Drugs"},{"key":"10.1016\/j.apsb.2026.05.027_bib34","first-page":"10","article-title":"Reflections on regulatory science for traditional Chinese medicine triggered by its current role in COVID-19 prevention and treatment","author":"Li","year":"2020","journal-title":"China Food Drug Regulation"},{"key":"10.1016\/j.apsb.2026.05.027_bib35","first-page":"147","article-title":"Analysis and reflections on the current status of regulatory science for traditional Chinese medicine","volume":"30","author":"Qiao","year":"2022","journal-title":"J Tradit Chin Med Manage"},{"key":"10.1016\/j.apsb.2026.05.027_bib36","first-page":"749","article-title":"Regulatory science for traditional Chinese medicine: enhancing scientific oversight at higher levels","volume":"58","author":"Zhao","year":"2023","journal-title":"Chin J Pharm"},{"key":"10.1016\/j.apsb.2026.05.027_bib37","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1360\/TB-2023-0364","article-title":"An introduction to regulatory science for traditional Chinese medicine aimed at high-quality development","volume":"68","author":"Tang","year":"2023","journal-title":"Chin Sci Bull"},{"key":"10.1016\/j.apsb.2026.05.027_bib38","first-page":"396","article-title":"Regulatory science for traditional Chinese medicine: an emerging convergent science in development","volume":"38","author":"Zhao","year":"2024","journal-title":"China Sci Fund"},{"key":"10.1016\/j.apsb.2026.05.027_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13020-025-01152-8","article-title":"From traditional medicine to modern medicine: the importance of traditional Chinese medicine regulatory science (TCMRS) as an emerging discipline","volume":"20","author":"Hua","year":"2025","journal-title":"Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib40","series-title":"Innovative textbook for higher education institutions during the 14th five-year plan period: regulatory science of traditional Chinese medicine","author":"Tang","year":"2024"},{"key":"10.1016\/j.apsb.2026.05.027_bib41","first-page":"200","article-title":"Top ten academic advances in traditional Chinese medicine in 2023","volume":"30","year":"2024","journal-title":"Chin J Exp Form"},{"key":"10.1016\/j.apsb.2026.05.027_bib42","first-page":"2","article-title":"Operational mechanism of the traditional Chinese medicine regulatory science research consortium (TCMRSC)","volume":"41","author":"Yu","year":"2025","journal-title":"Pharmacol Clin Appl Tradit Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib43","first-page":"6","article-title":"Discussion on regulatory science issues related to substitutes and extracts of rare and endangered Chinese medicinal materials","volume":"41","author":"Zhang","year":"2025","journal-title":"Chin Herb Med Pharmacol Clin Pract"},{"key":"10.1016\/j.apsb.2026.05.027_bib44","first-page":"12","article-title":"Discussion on regulatory science issues in the development of new traditional Chinese medicines based on preventive medicine","volume":"41","author":"Wang","year":"2025","journal-title":"Pharmacol Clin Med Tradit Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib45","first-page":"17","article-title":"Discussion on key scientific issues in clinical translation of syndrome-based traditional Chinese medicine new drugs","volume":"41","author":"Tang","year":"2025","journal-title":"Pharmacol Clin Appl Tradit Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib46","first-page":"56","article-title":"Introduction to the technical guidance principles system for pharmacological research of traditional Chinese medicine","author":"Zhao","year":"2021","journal-title":"China Food Drug Regulation"},{"key":"10.1016\/j.apsb.2026.05.027_bib47","first-page":"64","article-title":"Introduction and outlook of technical guidance principles for pharmaceutical research in traditional Chinese medicine registration","author":"Guan","year":"2021","journal-title":"China Food Drug Regulation"},{"key":"10.1016\/j.apsb.2026.05.027_bib48","first-page":"3574","article-title":"Evolution, current status, and outlook of technical guidance principles for clinical research of new traditional Chinese medicines in China","volume":"50","author":"Yang","year":"2025","journal-title":"Chin J Tradit Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib49","first-page":"1045","article-title":"Review and outlook on the development of China's drug technical guidance principle system","volume":"19","author":"Sha","year":"2022","journal-title":"Chin J Drug Safety"},{"key":"10.1016\/j.apsb.2026.05.027_bib50","first-page":"445","article-title":"Positioning of the \"three-combination\" registration review evidence system and expert consensus on the value orientation of \"human experience\"","volume":"48","author":"Wang","year":"2025","journal-title":"J Beijing Univ Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib51","first-page":"969","article-title":"Technical framework for traditional Chinese medicine theoretical research on new Chinese medicines under the 'three-combination\u2019 review evidence system","volume":"31","author":"Che","year":"2025","journal-title":"Chin J Basic Med Tradit Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib52","first-page":"1359","article-title":"Reflections on real-world research for new traditional Chinese medicines under the \"three-combination\" evidence system for registration review","volume":"31","author":"An","year":"2022","journal-title":"Chin J New Drugs"},{"key":"10.1016\/j.apsb.2026.05.027_bib53","first-page":"147","article-title":"Establishing a healthcare institution-based \"three-combination\" system for traditional Chinese medicine new drug R&D and management","volume":"38","author":"Lu","year":"2024","journal-title":"Chin J Pharm Affairs"},{"key":"10.1016\/j.apsb.2026.05.027_bib54","article-title":"Reflections on clinical research pathways and formulation of clinical research plans for new traditional Chinese medicines under the \u201cthree integrations\u201d review evidence system","author":"Song","year":"2026","journal-title":"Chin J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2026.05.027_bib55","series-title":"Announcement of the national Medical products administration on the release of \"Classification of Traditional Chinese Medicine Registration and Requirements for Application Materials\" (No. 68 of 2020)","year":"2020"},{"key":"10.1016\/j.apsb.2026.05.027_bib56","series-title":"Policy interpretation of \"Classification of Traditional Chinese Medicine Registration and Requirements for Application Materials\"","year":"2020"},{"key":"10.1016\/j.apsb.2026.05.027_bib57","article-title":"Historical evolution of classic prescriptions and their policy regulations","volume":"22","author":"Tie","year":"2026","journal-title":"Asia Pacific Tradit Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib58","first-page":"120","article-title":"Comparative study on registration regulations and technical requirements for herbal medicines in China, the United States, and the European Union","author":"Zhang","year":"2023","journal-title":"China Food Drug Regulation"},{"key":"10.1016\/j.apsb.2026.05.027_bib59","first-page":"6-27","article-title":"Prospecting the development of traditional Chinese medicine from a historical perspective","author":"Ma","year":"2023","journal-title":"China Food Drug Regulation"},{"key":"10.1016\/j.apsb.2026.05.027_bib60","first-page":"4-13","article-title":"Cultivating and strengthening national strategic scientific forces in drug regulation","author":"Zhao","year":"2023","journal-title":"China Food Drug Regulation"},{"key":"10.1016\/j.apsb.2026.05.027_bib61","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41392-025-02267-y","article-title":"Current landscape of innovative drug development and regulatory support in China","volume":"10","author":"Tan","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2026.05.027_bib62","first-page":"3408","article-title":"Application of the Gene-Encoded Natural Diverse Components (GNDC) database in traditional Chinese medicine research","volume":"60","author":"Yu","year":"2025","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.apsb.2026.05.027_bib63","article-title":"Artificial intelligence-curated repository of gene-encoded natural diverse components from herbal medicines","volume":"6","author":"Chen","year":"2025","journal-title":"Innovation"},{"key":"10.1016\/j.apsb.2026.05.027_bib64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eng.2023.09.011","article-title":"The application of artificial intelligence accelerates g protein-coupled receptor ligand discovery","volume":"32","author":"Chen","year":"2024","journal-title":"Engineering"},{"key":"10.1016\/j.apsb.2026.05.027_bib65","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.apsb.2024.06.023","article-title":"Genome-wide pan-GPCR cell libraries accelerate drug discovery","volume":"14","author":"Yang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.05.027_bib66","article-title":"Emerging paradigms for target discovery of traditional medicines: a genome-wide pan-GPCR perspective","volume":"6","author":"Bi","year":"2025","journal-title":"Innovation"},{"key":"10.1016\/j.apsb.2026.05.027_bib67","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13020-024-00964-4","article-title":"G protein-coupled receptors and traditional Chinese medicine: new perspectives for the development of traditional Chinese medicine","volume":"19","author":"Zhang","year":"2024","journal-title":"Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib68","first-page":"2375","article-title":"A novel strategy for traditional Chinese medicine development and evaluation based on genome-wide pan-receptor target screening","volume":"60","author":"Zhang","year":"2025","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.apsb.2026.05.027_bib69","article-title":"Phenotype\u2013target coupled drug screening: a high-efficiency framework for innovative drug discovery from CHMs","author":"Zhou","year":"2025","journal-title":"Engineering"},{"key":"10.1016\/j.apsb.2026.05.027_bib70","doi-asserted-by":"crossref","first-page":"12651","DOI":"10.1021\/acs.jmedchem.2c01737","article-title":"Is target-based drug discovery efficient? Discovery and \"off-target\" mechanisms of all drugs","volume":"66","author":"Sadri","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.05.027_bib71","first-page":"5305","article-title":"A new interpretation of the complexity principle in traditional Chinese medicine: formula nanoparticles (FDN) as the ideal form of active compounds enabling multi-level targeted regulation of disease dynamic networks","volume":"50","author":"Zhao","year":"2025","journal-title":"Chinese J Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib72","article-title":"The principle of formula nanoparticles: how Chinese herbal decoctions transition from complex black boxes to clear transparency","author":"Ai","year":"2026","journal-title":"Chin J Pharmacol Clin Med"},{"issue":"16","key":"10.1016\/j.apsb.2026.05.027_bib73","first-page":"1661","article-title":"Formula nanobody drug discovery (FDD): a novel strategy for multitarget drug innovation and new drug discovery","volume":"60","author":"Zhao","year":"2025","journal-title":"Chin J Pharm"},{"key":"10.1016\/j.apsb.2026.05.027_bib74","article-title":"Nanoscale science of traditional Chinese medicine: principles of formulary nanoparticles and advanced therapeutic products","author":"Hua","year":"2026","journal-title":"Chin J Tradit Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib75","first-page":"1627","article-title":"Empowering clinical research of new traditional Chinese medicine drugs with new quality productivity: current status, challenges, and prospects","volume":"26","author":"Xie","year":"2024","journal-title":"Chin J Modern Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib76","series-title":"Modernize testing. U.S. Senate Passes FDA Modernization Act 3.0 by unanimous consent, validating the federal government's transition from animal testing","year":"2025"},{"key":"10.1016\/j.apsb.2026.05.027_bib77","article-title":"Senate clears FDA modernization act 3.0, aiming to align FDA regulations with nonclinical-testing reforms","author":"Buntz","year":"2025","journal-title":"Drug Discov Dev"},{"key":"10.1016\/j.apsb.2026.05.027_bib78","unstructured":"FDA. Roadmap to reducing animal testing in preclinical safety studies. Available from: https:\/\/www.fda.gov\/media\/186092\/download."},{"key":"10.1016\/j.apsb.2026.05.027_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","article-title":"Artificial intelligence in drug development","volume":"31","author":"Zhang","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib80","first-page":"674","article-title":"Artificial intelligence in traditional Chinese medicine: systematic insights from data mining, large language models, and multimodal fusion","volume":"4","author":"Yin","year":"2025","journal-title":"Acta Mater Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib81","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41392-023-01339-1","article-title":"TCMBank\u2014the largest traditional Chinese medicine database provides deep learning-based Chinese\u2013Western medicine exclusion prediction","volume":"8","author":"Lv","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2026.05.027_bib82","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/wjtcm.wjtcm_11_21","article-title":"Network pharmacology evaluation method guidance\u2014draft","volume":"7","author":"Li","year":"2021","journal-title":"World J Tradit Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib83","article-title":"Network pharmacology: towards artificial intelligence-based precision traditional Chinese medicine","volume":"25","author":"Zhang","year":"2024","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.apsb.2026.05.027_bib84","first-page":"77","article-title":"Top ten academic advances in traditional Chinese medicine in 2024","volume":"11","author":"Guo","year":"2025","journal-title":"World J Integr Tradit West Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib85","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41392-021-00475-w","article-title":"Evaluation of the immunomodulatory effects of anti-COVID-19 traditional Chinese medicine formulae by multiple virus-related pathways","volume":"6","author":"Qiao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2026.05.027_bib86","first-page":"200","article-title":"Organoids: a new model for antitumor drug research","volume":"38","author":"Li","year":"2022","journal-title":"Pharmacol Clin Appl Tradit Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156721","article-title":"Zengmian Yiliu formula suppresses cell cycle in immune-rich ovarian cancer patient-derived organoids","volume":"141","author":"Cao","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.apsb.2026.05.027_bib88","first-page":"68","article-title":"A stroke organoids-multiomics platform to study injury mechanism and drug response","volume":"44","author":"Zhu","year":"2025","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2026.05.027_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100667","article-title":"Organoids and organs-on-chips: recent advances, applications in drug development, and regulatory challenges","volume":"6","author":"Zhou","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2025.03.041","article-title":"Recent advances in blood-brain barrier-on-a-chip models","volume":"197","author":"Vetter","year":"2025","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2026.05.027_bib91","series-title":"Establishment of a traditional Chinese medicine hepatotoxicity and nephrotoxicity evaluation system based on microfluidic organ-on-a-chip technology","first-page":"74","author":"Lin","year":"2024"},{"key":"10.1016\/j.apsb.2026.05.027_bib92","first-page":"43","article-title":"Quality bioevaluation of Angelica dahurica, Ligusticum chuanxiong, and their compound preparation Duliang soft capsules based on Microtox technology","volume":"39","author":"Tian","year":"2023","journal-title":"Pharmacol Clin Appl Tradit Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib93","first-page":"137","article-title":"Rapid evaluation of comprehensive toxicity of traditional Chinese medicines based on microtox technology (Microtoxicity Testing)","volume":"9","author":"Zhao","year":"2014","journal-title":"World J Tradit Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib94","first-page":"2189","article-title":"Progress in quality fluctuation and safety risk early warning of traditional Chinese medicine injections based on microtoxicity detection","volume":"54","author":"Yan","year":"2019","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.apsb.2026.05.027_bib95","first-page":"1136","article-title":"Key considerations and reflections on the design of pharmacodynamic trials for new traditional Chinese medicine drugs","volume":"39","author":"Huang","year":"2014","journal-title":"Chin J Chin Med"},{"key":"10.1016\/j.apsb.2026.05.027_bib96","first-page":"6933","article-title":"Key considerations for non-clinical research in clinical trial applications of traditional Chinese medicine compound preparations","volume":"54","author":"Zhou","year":"2023","journal-title":"Chin Herb Drugs"},{"key":"10.1016\/j.apsb.2026.05.027_bib97","first-page":"22","article-title":"Development strategy for modernization of traditional Chinese medicine","author":"Gan","year":"2000","journal-title":"Med Res Commun"},{"key":"10.1016\/j.apsb.2026.05.027_bib98","first-page":"4","article-title":"Frontiers of biomedical technology innovation, China's development trends, and reflections on the new phase","author":"Chen","year":"2021","journal-title":"China Food Drug Regulation"},{"key":"10.1016\/j.apsb.2026.05.027_bib99","first-page":"3","article-title":"Progress of the national major new drug innovation program in 2018 and outlook for the 13th five-year plan period","volume":"39","author":"Sang","year":"2019","journal-title":"Chin J Bioeng"},{"key":"10.1016\/j.apsb.2026.05.027_bib100","first-page":"1","article-title":"A decade review and outlook of the major special project for innovation of major new drugs","volume":"7","author":"Zhang","year":"2017","journal-title":"Acta Neuropharmacol Sin"},{"key":"10.1016\/j.apsb.2026.05.027_bib101","series-title":"Traditional Chinese medicine research thrives","year":"2025"},{"key":"10.1016\/j.apsb.2026.05.027_bib102","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5582\/ddt.2024.01055","article-title":"Tailored to fit: china optimizes policies and regulations regarding drug registration and review to promote innovation in traditional Chinese medicine","volume":"18","author":"Lu","year":"2024","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.apsb.2026.05.027_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108752","article-title":"New drug discovery and development from natural products: advances and strategies","volume":"264","author":"Wang","year":"2024","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.05.027_bib104","first-page":"217","article-title":"Research on the management of national major science and technology projects under high uncertainty: taking the major new drug innovation program as an example","volume":"22","author":"Lu","year":"2022","journal-title":"Sci Indust"},{"key":"10.1016\/j.apsb.2026.05.027_bib105","series-title":"Barriers to innovations in pharmaceutical manufacturing: proceedings of a Workshop-in brief","year":"2020"},{"key":"10.1016\/j.apsb.2026.05.027_bib106","first-page":"1","article-title":"Promoting integrated development of medicine through parallel advancement of technological innovation and policy implementation","volume":"10","author":"Cao","year":"2026","journal-title":"Chin Med J"},{"key":"10.1016\/j.apsb.2026.05.027_bib107","first-page":"5896","article-title":"Strategies for establishing a benefit-risk assessment system for traditional Chinese medicine and its development prospects","volume":"50","author":"Li","year":"2025","journal-title":"Chin J Tradit Chin Med"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526003205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526003205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T10:57:01Z","timestamp":1786013821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526003205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":107,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2211383526003205"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.05.027","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-driven by regulatory science and policy reconstruction: Traditional Chinese medicine (TCM) new drugs accelerate development\u2014A critical review of highlights in registration and regulation of TCM and natural medicine new drugs in China (2021\u20132025)","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}